期刊文献+

苹果酸奈诺沙星的合成 被引量:2

Synthesis of Nemonoxacin Malate
原文传递
导出
摘要 1-环丙基-7-氟-8-甲氧基-4-氧代-1,4-二氢喹啉-3-羧酸乙酯与硼酸、乙酐反应得1-环丙基-7-氟-8-甲氧基-4-氧代-1,4-二氢喹啉-3-羧酸根-O^3,O^4-二乙酸根合硼,与(3S,5S)-(5-甲基哌啶-3-基)氨基甲酸叔丁酯经偶联、碱解和酸解"一锅"反应得奈诺沙星,最后成苹果酸盐制得无氟喹诺酮抗菌药苹果酸奈诺沙星,总收率约65%。 Ethyl 1-cyclopropyl_7.fluoro_8-methoxyl-4-oxo-l,4-dihydroquinoline-3-carboxylate was reacted with boric acid and acetic anhydride to give 1-cyclopropyl-7.fluoro-8-methoxy-4-oxo-l,4-dihydroquinoline-3-carboxylic- O3,O4-diacetyl boron complex, which was coupled with tert-butyl (3S,5S) - (5-methylpeperidin-3-yl) carbamate and then hydrolyzed by sodium hydroxide and hydrochloric acid separately to provide nemonoxacin in one pot. Nemonoxacin malate, a nonflourinated quinolone antibacterial agent, was obtained by salt formation with an overall yield of about 65 %.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2014年第2期101-103,共3页 Chinese Journal of Pharmaceuticals
关键词 奈诺沙星 无氟喹诺酮 抗菌药 合成 nemonoxacin nonflourinated quinolone antibacterial agent synthesis
  • 相关文献

参考文献5

二级参考文献34

  • 1Andersson MI,MacGowan AP.Development of the quinolones[J].J Antimicrob Chemother,2003,51(Suppl 1):1-11.
  • 2Arjona A.Nemonoxacin[l].Drugs Future,2009,34(3):196-203.
  • 3Roychoudhury S,Twinem TL,Makin KM,et al.Activity of non-fluorinated quinolones (NFQs)against quinolone-resistant Escherichia coli and Streptococcus pneumoniae[J].J Antimicrob Chemother,2001,48(1):29-36.
  • 4Chen YH,Liu CY,Lu JJ,et al.In vitro activity of nemonoxacin (TG-873870),a novel non-fluorinated quinolone,against clinical isolates of Staphylococcus aureus,enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan[J].J Antimicrob Chemother,2009,64(6):1226-1229.
  • 5Adam HJ,Laing NM,King CR,et al.In vitro activity of nemonoxacin,a novel nonfluorinated quinolone,against 2440 clinical isolates[J].Antimicrob Agents Chemother,2009,53(11):4915-4920.
  • 6Zhanel GG,DeCorby M,Adarn H,et al.Prevalence of antimicrobial-resistant pathogens in Canadian hospitals:results of the Canadian Ward Surveillance Study (CANWARD 2008)[J].Antimicrob Agents Chemother,2010,54 (11):4684-4693.
  • 7Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing.Eighteenth informational supplement.MI00-S18[S].Clinical and Laboratory Standards Institute,Wayne,PA.
  • 8Nichol KA,Adarn HJ.Hussain Z,et al.Comparison of community-associated and health care-associated methicillinresistant Staphylococcus aureus in Canada:results of the CA,NWARD 2007-2009 study[J].Diagn Microbiol Infect Dis.2011,69(3):320-325.
  • 9Lai CC,Tan CK,Lin SH,et al.Comparative in vitro activiities of nemonoxacin,doripenem,tigecycline and 16 other antimicrobials against Nocardia brasiliensis,Nocardia asteroids and unusual Nocardia species[J].J Antimicrob Chemother,2009,64(1):73-78.
  • 10Gomez FA,Welsh O.Said FS,et al.In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis[J].Antimicrob Agents Chemother,2004,48(3):832-837.

共引文献11

同被引文献13

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部